Inbija’s “Now Approved” Pages for Patients and HCPs Jan 9, 2019Jan 8, 2019 Brand: Inbrija (levodopa), Inhalation Powder Parent Company: Acorda Therapeutics Drug Type: Prescription Drug Category: Neurology Campaign: now-approved Targeting: HCPs, Patients, Caregivers Patient Website: https://www.inbrija.com/ HCP Website: https://www.inbrija-hcp.com/ Patient Page Patient Page (Mobile) HPC Page Request a Rep modal